Literature DB >> 20687133

Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1.

Irina Protasevich1, Zhengrong Yang, Chi Wang, Shane Atwell, Xun Zhao, Spencer Emtage, Diana Wetmore, John F Hunt, Christie G Brouillette.   

Abstract

Misfolding and degradation of CFTR is the cause of disease in patients with the most prevalent CFTR mutation, an in-frame deletion of phenylalanine (F508del), located in the first nucleotide-binding domain of human CFTR (hNBD1). Studies of (F508del)CFTR cellular folding suggest that both intra- and inter-domain folding is impaired. (F508del)CFTR is a temperature-sensitive mutant, that is, lowering growth temperature, improves both export, and plasma membrane residence times. Yet, paradoxically, F508del does not alter the fold of isolated hNBD1 nor did it seem to perturb its unfolding transition in previous isothermal chemical denaturation studies. We therefore studied the in vitro thermal unfolding of matched hNBD1 constructs ±F508del to shed light on the defective folding mechanism and the basis for the thermal instability of (F508del)CFTR. Using primarily differential scanning calorimetry (DSC) and circular dichroism, we show for all hNBD1 pairs studied, that F508del lowers the unfolding transition temperature (T(m)) by 6-7°C and that unfolding occurs via a kinetically-controlled, irreversible transition in isolated monomers. A thermal unfolding mechanism is derived from nonlinear least squares fitting of comprehensive DSC data sets. All data are consistent with a simple three-state thermal unfolding mechanism for hNBD1 ± F508del: N(±MgATP) <==> I(T)(±MgATP) → A(T) → (A(T))(n). The equilibrium unfolding to intermediate, I(T), is followed by the rate-determining, irreversible formation of a partially folded, aggregation-prone, monomeric state, A(T), for which aggregation to (A(T))(n) and further unfolding occur with no detectable heat change. Fitted parameters indicate that F508del thermodynamically destabilizes the native state, N, and accelerates the formation of A(T).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20687133      PMCID: PMC2998726          DOI: 10.1002/pro.479

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  50 in total

Review 1.  Interpreting the effects of small uncharged solutes on protein-folding equilibria.

Authors:  P R Davis-Searles; A J Saunders; D A Erie; D J Winzor; G J Pielak
Journal:  Annu Rev Biophys Biomol Struct       Date:  2001

2.  Domain interdependence in the biosynthetic assembly of CFTR.

Authors:  Liying Cui; Luba Aleksandrov; Xiu-Bao Chang; Yue-Xian Hou; Lihua He; Tamas Hegedus; Martina Gentzsch; Andrei Aleksandrov; William E Balch; John R Riordan
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

3.  Thermodynamic puzzle of apomyoglobin unfolding.

Authors:  Y V Griko; P L Privalov
Journal:  J Mol Biol       Date:  1994-01-28       Impact factor: 5.469

4.  Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant.

Authors:  Shane Atwell; Christie G Brouillette; Kris Conners; Spencer Emtage; Tarun Gheyi; William B Guggino; Jorg Hendle; John F Hunt; Hal A Lewis; Frances Lu; Irina I Protasevich; Logan A Rodgers; Rich Romero; Stephen R Wasserman; Patricia C Weber; Diana Wetmore; Feiyu F Zhang; Xun Zhao
Journal:  Protein Eng Des Sel       Date:  2010-02-11       Impact factor: 1.650

5.  Scan-rate-dependent melting transitions of interleukin-1 receptor (type II): elucidation of meaningful thermodynamic and kinetic parameters of aggregation acquired from DSC simulations.

Authors:  Richard L Remmele; Jian Zhang-van Enk; Vasu Dharmavaram; David Balaban; Mark Durst; Alex Shoshitaishvili; Hugh Rand
Journal:  J Am Chem Soc       Date:  2005-06-15       Impact factor: 15.419

6.  Structure and dynamics of NBD1 from CFTR characterized using crystallography and hydrogen/deuterium exchange mass spectrometry.

Authors:  H A Lewis; C Wang; X Zhao; Y Hamuro; K Conners; M C Kearins; F Lu; J M Sauder; K S Molnar; S J Coales; P C Maloney; W B Guggino; D R Wetmore; P C Weber; J F Hunt
Journal:  J Mol Biol       Date:  2009-11-26       Impact factor: 5.469

7.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive.

Authors:  G M Denning; M P Anderson; J F Amara; J Marshall; A E Smith; M J Welsh
Journal:  Nature       Date:  1992-08-27       Impact factor: 49.962

8.  The DeltaF508 mutation disrupts packing of the transmembrane segments of the cystic fibrosis transmembrane conductance regulator.

Authors:  Eva Y Chen; M Claire Bartlett; Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

9.  Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces.

Authors:  J-P Mornon; P Lehn; I Callebaut
Journal:  Cell Mol Life Sci       Date:  2008-08       Impact factor: 9.261

10.  Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function.

Authors:  Adrian W R Serohijos; Tamás Hegedus; Andrei A Aleksandrov; Lihua He; Liying Cui; Nikolay V Dokholyan; John R Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-27       Impact factor: 11.205

View more
  60 in total

1.  Allosteric modulation balances thermodynamic stability and restores function of ΔF508 CFTR.

Authors:  Andrei A Aleksandrov; Pradeep Kota; Liying Cui; Tim Jensen; Alexey E Alekseev; Santiago Reyes; Lihua He; Martina Gentzsch; Luba A Aleksandrov; Nikolay V Dokholyan; John R Riordan
Journal:  J Mol Biol       Date:  2012-03-08       Impact factor: 5.469

2.  Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.

Authors:  Xuehong Liu; Nicolette O'Donnell; Allison Landstrom; William R Skach; David C Dawson
Journal:  Biochemistry       Date:  2012-06-15       Impact factor: 3.162

3.  Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.

Authors:  Rhea P Hudson; P Andrew Chong; Irina I Protasevich; Robert Vernon; Efrat Noy; Hermann Bihler; Jian Li An; Ori Kalid; Inbal Sela-Culang; Martin Mense; Hanoch Senderowitz; Christie G Brouillette; Julie D Forman-Kay
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

4.  Using a second-order differential model to fit data without baselines in protein isothermal chemical denaturation.

Authors:  Chuanning Tang; Scott Lew; Dacheng He
Journal:  Protein Sci       Date:  2016-02-11       Impact factor: 6.725

5.  Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains.

Authors:  Zhengrong Yang; Chi Wang; Qingxian Zhou; Jianli An; Ellen Hildebrandt; Luba A Aleksandrov; John C Kappes; Lawrence J DeLucas; John R Riordan; Ina L Urbatsch; John F Hunt; Christie G Brouillette
Journal:  Protein Sci       Date:  2014-05-03       Impact factor: 6.725

6.  Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.

Authors:  Wael M Rabeh; Florian Bossard; Haijin Xu; Tsukasa Okiyoneda; Miklos Bagdany; Cory M Mulvihill; Kai Du; Salvatore di Bernardo; Yuhong Liu; Lars Konermann; Ariel Roldan; Gergely L Lukacs
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

7.  Thermal stability of purified and reconstituted CFTR in a locked open channel conformation.

Authors:  Luba A Aleksandrov; Timothy J Jensen; Liying Cui; Joseph N Kousouros; Lihua He; Andrei A Aleksandrov; John R Riordan
Journal:  Protein Expr Purif       Date:  2015-09-15       Impact factor: 1.650

Review 8.  Ion Channel Modulators in Cystic Fibrosis.

Authors:  Martina Gentzsch; Marcus A Mall
Journal:  Chest       Date:  2018-05-08       Impact factor: 9.410

Review 9.  Dynamics intrinsic to cystic fibrosis transmembrane conductance regulator function and stability.

Authors:  P Andrew Chong; Pradeep Kota; Nikolay V Dokholyan; Julie D Forman-Kay
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Ligand binding to a remote site thermodynamically corrects the F508del mutation in the human cystic fibrosis transmembrane conductance regulator.

Authors:  Chi Wang; Andrei A Aleksandrov; Zhengrong Yang; Farhad Forouhar; Elizabeth A Proctor; Pradeep Kota; Jianli An; Anna Kaplan; Netaly Khazanov; Grégory Boël; Brent R Stockwell; Hanoch Senderowitz; Nikolay V Dokholyan; John R Riordan; Christie G Brouillette; John F Hunt
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.